Clinical Trials · NCT04760782

PTH Analog Type II Odontoid Fracture

TerminatedPhase 2Abaloparatide (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
David Lunardini
Enrollment
22
Start date
May 2022
Locations
1 site, United States
Primary endpoint
Fracture Union
View Abaloparatide compound reference